These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 16931303)

  • 1. Left hepatic trisectionectomy for hepatobiliary malignancies.
    Lang H; Sotiropoulos GC; Brokalaki EI; Radtke A; Frilling A; Molmenti EP; Malagó M; Broelsch CE
    J Am Coll Surg; 2006 Sep; 203(3):311-21. PubMed ID: 16931303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic resection: effective treatment for primary and secondary tumors.
    Buell JF; Rosen S; Yoshida A; Labow D; Limsrichamrern S; Cronin DC; Bruce DS; Wen M; Michelassi F; Millis JM; Posner MC
    Surgery; 2000 Oct; 128(4):686-93. PubMed ID: 11015103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of left trisectionectomy for perihilar cholangiocarcinoma: an appraisal and comparison with left hepatectomy.
    Natsume S; Ebata T; Yokoyama Y; Igami T; Sugawara G; Shimoyama Y; Nagino M
    Ann Surg; 2012 Apr; 255(4):754-62. PubMed ID: 22367444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caudate hepatectomy for cancer: a single institution experience with 150 patients.
    Hawkins WG; DeMatteo RP; Cohen MS; Jarnagin WR; Fong Y; D'Angelica M; Gonen M; Blumgart LH
    J Am Coll Surg; 2005 Mar; 200(3):345-52. PubMed ID: 15737844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatectomy and pancreatectomy with combined vascular resection in patients with hepato-biliary and pancreas diseases at a single cancer institute.
    Nanashima A; Yamaguchi H; Sumida Y; Abo T; Tobinaga S; Tanaka K; Takeshita H; Hidaka S; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2008; 55(84):873-8. PubMed ID: 18705286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right trisectionectomy with principle en bloc portal vein resection for right-sided hilar cholangiocarcinoma: no-touch technique.
    Machado MA; Makdissi FF; Surjan RC
    Ann Surg Oncol; 2012 Apr; 19(4):1324-5. PubMed ID: 21997349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome.
    Nagino M; Kamiya J; Arai T; Nishio H; Ebata T; Nimura Y
    Surgery; 2005 Feb; 137(2):148-55. PubMed ID: 15674194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic resection for primary or secondary malignancies with involvement of the inferior vena cava: is this operation safe or hazardous?
    Nardo B; Ercolani G; Montalti R; Bertelli R; Gardini A; Beltempo P; Puviani L; Pacilè V; Vivarelli M; Cavallari A
    J Am Coll Surg; 2005 Nov; 201(5):671-9. PubMed ID: 16256908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal vein resection and reconstruction prior to hepatic dissection during right hepatectomy and caudate lobectomy for hepatobiliary cancer.
    Kondo S; Katoh H; Hirano S; Ambo Y; Tanaka E; Okushiba S
    Br J Surg; 2003 Jun; 90(6):694-7. PubMed ID: 12808616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy.
    Shimizu H; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Miyazaki M
    Ann Surg; 2010 Feb; 251(2):281-6. PubMed ID: 20054275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer.
    Aoki T; Sugawara Y; Imamura H; Seyama Y; Minagawa M; Hasegawa K; Kokudo N; Makuuchi M
    J Am Coll Surg; 2004 Mar; 198(3):366-72. PubMed ID: 14992737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of hepatic resection combined with inferior vena cava resection and its reconstruction with expanded polytetrafluoroethylene for treatment of liver tumors.
    Arii S; Teramoto K; Kawamura T; Takamatsu S; Sato E; Nakamura N; Iwai T; Mori A; Tanaka J; Imamura M
    J Am Coll Surg; 2003 Feb; 196(2):243-9. PubMed ID: 12595053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Partial hepatectomy with skeletonization of the hepatoduodenal ligament for hilar cholangiocarcinoma].
    Jiang XQ; Zhang BH; Yi B; Chen H; Wu MC
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(4):210-2. PubMed ID: 15062037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes.
    Baton O; Azoulay D; Adam DV; Castaing D
    J Am Coll Surg; 2007 Feb; 204(2):250-60. PubMed ID: 17254929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical margin status in hepatectomy for liver tumors].
    Salloum C; Castaing D
    Bull Cancer; 2008 Dec; 95(12):1183-91. PubMed ID: 19091652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete resection of the caudate lobe of the liver with tumor: technique and experience.
    Fan J; Wu ZQ; Tang ZY; Zhou J; Qiu SJ; Ma ZC; Zhou XD; Yu YQ
    Hepatogastroenterology; 2001; 48(39):808-11. PubMed ID: 11462929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is radical hepatic surgery safe?
    Brancatisano R; Isla A; Habib N
    Am J Surg; 1998 Feb; 175(2):161-3. PubMed ID: 9515537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?
    Miyazaki M; Kato A; Ito H; Kimura F; Shimizu H; Ohtsuka M; Yoshidome H; Yoshitomi H; Furukawa K; Nozawa S
    Surgery; 2007 May; 141(5):581-8. PubMed ID: 17462457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of trisectionectomy for hepatocellular carcinoma.
    Zhou Y; Sui C; Li B; Kan T; Yang J; Wu M
    ANZ J Surg; 2011 Dec; 81(12):895-9. PubMed ID: 22507416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.